Company intelligence / Profile preview
Guangzhou Saijun Biotechnology Co., Ltd.
Guangzhou, Guangdong, Chinayuanvore.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Guangzhou Saijun Biotechnology develops allogeneic human bone marrow-derived mesenchymal stem cell therapies. Its lead product "CG-BM1" has received clinical implied approval in China for treating moderate/severe adult ARDS caused by infection since at least 2021. In December 2022, the company filed an IND application for a new indication—chronic and acute liver failure—which was accepted by Chinese regulators. The company appears focused on advancing its MSC-based therapies through clinical development targeting severe inflammatory and organ failure conditions.
- Therapeutic areas
- GastroenterologyPulmonology
- Modalities
- Allogeneic mesenchymal stem cells (MSCs)Cell therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Guangzhou Saijun Biotechnology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangzhou Saijun Biotechnology Co., Ltd..